Matches in Wikidata for { <http://www.wikidata.org/entity/Q65542838> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- Q65542838 description "clinical trial" @default.
- Q65542838 description "ensayu clínicu" @default.
- Q65542838 description "klinisch onderzoek" @default.
- Q65542838 description "клінічне випробування" @default.
- Q65542838 name "Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness" @default.
- Q65542838 name "Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness" @default.
- Q65542838 type Item @default.
- Q65542838 label "Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness" @default.
- Q65542838 label "Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness" @default.
- Q65542838 prefLabel "Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness" @default.
- Q65542838 prefLabel "Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness" @default.
- Q65542838 P1050 Q65542838-1E1BE3B3-60E1-42BE-B803-42E867AC1128 @default.
- Q65542838 P1050 Q65542838-B0139393-4322-4943-80D9-8051FC2E30A0 @default.
- Q65542838 P1132 Q65542838-9166650E-B9EB-4037-9255-6660B1C11CE2 @default.
- Q65542838 P131 Q65542838-3E9F9EF3-B2EA-47DB-A0E6-B7BAA74F559C @default.
- Q65542838 P1476 Q65542838-CD3B8F76-EE39-4C5B-ABD1-5179DA680727 @default.
- Q65542838 P17 Q65542838-84DDE36E-4211-42E3-B5CE-13F7261B4583 @default.
- Q65542838 P17 Q65542838-9535F9CA-42B6-4B62-898E-643E67DECFFF @default.
- Q65542838 P17 Q65542838-BD40F4F8-9902-4FBC-995A-E02C9CB97AF7 @default.
- Q65542838 P17 Q65542838-EF565239-289E-416E-BAC3-1D3CC93ECA66 @default.
- Q65542838 P17 Q65542838-FE24F099-EAB8-4A13-B776-8A7CD5B44B4A @default.
- Q65542838 P2899 Q65542838-A425DEEE-0DEC-4EAF-868C-358B3C39F6D2 @default.
- Q65542838 P3098 Q65542838-C05C9895-8DFF-4491-A1E7-64D2BFA934F2 @default.
- Q65542838 P31 Q65542838-4CD318AB-CBA8-44FE-A314-0EE29DD7F45C @default.
- Q65542838 P4135 Q65542838-5C8EBE2D-408C-4E17-9D68-F4BFEC43B758 @default.
- Q65542838 P4844 Q65542838-FA682FAF-F6A9-49A3-A69D-97AC7B798223 @default.
- Q65542838 P580 Q65542838-B40B066B-D709-4BD7-8919-952502D0DA13 @default.
- Q65542838 P6099 Q65542838-1D136C63-E6B5-4C11-A659-F7DC4B310E92 @default.
- Q65542838 P6153 Q65542838-04806AC4-020C-4851-895D-BB6F8EC74817 @default.
- Q65542838 P6153 Q65542838-05A7F876-2627-416A-AA66-5E09DCF71406 @default.
- Q65542838 P6153 Q65542838-12BA0D12-4338-4D52-A9B0-8EA117DEE5A7 @default.
- Q65542838 P6153 Q65542838-3564F088-FAE1-485C-A322-222091C15BF6 @default.
- Q65542838 P6153 Q65542838-3BA6F7FA-863D-415C-9C4C-DB2FE5AC9537 @default.
- Q65542838 P6153 Q65542838-3C9CA8D2-A33C-49D2-8CC1-9C6F478FD09B @default.
- Q65542838 P6153 Q65542838-4978E247-438B-456B-AD88-04200203F068 @default.
- Q65542838 P6153 Q65542838-4ECF773B-26E2-48A9-B60B-04FD69FD391D @default.
- Q65542838 P6153 Q65542838-562A0326-C6CC-4C65-A9B9-19E915A0E59A @default.
- Q65542838 P6153 Q65542838-5F2E94C6-D19E-4685-A09C-2EAC36914939 @default.
- Q65542838 P6153 Q65542838-8C3E8ACB-5272-42C5-A5C0-4051AFAF526F @default.
- Q65542838 P6153 Q65542838-97428749-1E2B-40E4-B695-EF61DB2065B7 @default.
- Q65542838 P6153 Q65542838-9F8468B8-5812-4E84-9366-FFA26A4DFB9D @default.
- Q65542838 P6153 Q65542838-AE632318-0C07-4E96-98C2-1F46ECDCCDF5 @default.
- Q65542838 P6153 Q65542838-B583A9F0-BBCB-4097-A3E4-A700A04F45C6 @default.
- Q65542838 P6153 Q65542838-BF6B143E-1471-478A-9530-00C3C40BA0C8 @default.
- Q65542838 P6153 Q65542838-EC413716-956A-46C8-A480-AE6B08241581 @default.
- Q65542838 P8363 Q65542838-B1B21CB9-C1B3-4C1B-A652-2E9A052F748B @default.
- Q65542838 P1050 Q179630 @default.
- Q65542838 P1050 Q189561 @default.
- Q65542838 P1132 "+743" @default.
- Q65542838 P131 Q1183 @default.
- Q65542838 P1476 "A 12-Month, Open-Label, Flexible-Dosage (100 to 250 mg/Day) Extension Study of the Safety and Efficacy of Armodafinil (CEP-10953) in the Treatment of Patients With Excessive Sleepiness Associated With Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder (With an Open-Ended Extension Period)" @default.
- Q65542838 P17 Q142 @default.
- Q65542838 P17 Q16 @default.
- Q65542838 P17 Q183 @default.
- Q65542838 P17 Q30 @default.
- Q65542838 P17 Q408 @default.
- Q65542838 P2899 "+18" @default.
- Q65542838 P3098 "NCT00228553" @default.
- Q65542838 P31 Q30612 @default.
- Q65542838 P4135 "+65" @default.
- Q65542838 P4844 Q410441 @default.
- Q65542838 P580 "2004-05-01T00:00:00Z" @default.
- Q65542838 P6099 Q42824827 @default.
- Q65542838 P6153 Q153987 @default.
- Q65542838 P6153 Q30254145 @default.
- Q65542838 P6153 Q30270192 @default.
- Q65542838 P6153 Q30298472 @default.
- Q65542838 P6153 Q3145132 @default.
- Q65542838 P6153 Q4117596 @default.
- Q65542838 P6153 Q41506 @default.
- Q65542838 P6153 Q4354672 @default.
- Q65542838 P6153 Q43896488 @default.
- Q65542838 P6153 Q49210 @default.
- Q65542838 P6153 Q5312894 @default.
- Q65542838 P6153 Q574571 @default.
- Q65542838 P6153 Q598841 @default.
- Q65542838 P6153 Q6905066 @default.
- Q65542838 P6153 Q7374738 @default.
- Q65542838 P6153 Q7826568 @default.
- Q65542838 P6153 Q7989074 @default.
- Q65542838 P8363 Q78089383 @default.